Cargando…

Impact of 1% chlorhexidine gluconate bathing and emollient application on bacterial pathogen colonization dynamics in hospitalized preterm neonates – A pilot clinical trial

BACKGROUND: Chlorhexidine gluconate (CHG) body washes and emollient application may modulate bacterial pathogen colonization and prevent neonatal hospital-acquired infections. METHODS: This pilot, non-randomized, open-label trial, enrolled preterm neonates (1000-1500g; day 1-3 of life) at a tertiary...

Descripción completa

Detalles Bibliográficos
Autores principales: Dramowski, Angela, Pillay, Sheylyn, Bekker, Adrie, Abrahams, Ilhaam, Cotton, Mark F., Coffin, Susan E., Whitelaw, Andrew C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225683/
https://www.ncbi.nlm.nih.gov/pubmed/34195575
http://dx.doi.org/10.1016/j.eclinm.2021.100946
_version_ 1783712133622530048
author Dramowski, Angela
Pillay, Sheylyn
Bekker, Adrie
Abrahams, Ilhaam
Cotton, Mark F.
Coffin, Susan E.
Whitelaw, Andrew C.
author_facet Dramowski, Angela
Pillay, Sheylyn
Bekker, Adrie
Abrahams, Ilhaam
Cotton, Mark F.
Coffin, Susan E.
Whitelaw, Andrew C.
author_sort Dramowski, Angela
collection PubMed
description BACKGROUND: Chlorhexidine gluconate (CHG) body washes and emollient application may modulate bacterial pathogen colonization and prevent neonatal hospital-acquired infections. METHODS: This pilot, non-randomized, open-label trial, enrolled preterm neonates (1000-1500g; day 1-3 of life) at a tertiary hospital in Cape Town, South Africa. Participants were sequentially allocated to 4 trial arms (n=20 each): 1% aqueous CHG (CHG), 1% CHG plus emollient (CHG+EM), emollient only (EM) and standard of care (SOC: no antiseptic/emollient). Trial treatment/s were applied daily for 10 days (d) post-enrolment, documenting neonatal skin condition score. Anterior nose, neck, umbilical and perianal swabs for bacterial culture were collected at d1, d3, d10 and d16 post-enrolment, (±1 day), reporting pathogen acquisition rates and semi-quantitative bacterial colony counts. (ClinicalTrials.gov identifier: NCT03896893; trial status: closed). FINDINGS: Eighty preterm neonates (mean gestational age 30 weeks [SD 2]) were enrolled between 4 March and 26 August 2019. The bacterial pathogen acquisition rate (comparing d1 and d16 swabs) varied from 33·9% [95%CI 22·9-47·0] at the umbilicus, 39·3% [95%CI 27·6-52·4] at the neck, to 71·4% [95%CI 58·5-81·7] at both the nose and perianal region. At d10, CHG babies had reduced bacterial density detected from neck, umbilicus, and perianal swabs compared to other groups (see Table 3). Following intervention cessation, colonization density was similar across all trial arms, but S. aureus colonization was more prevalent among EM and CHG+EM babies. Neonatal skin condition score improved in babies receiving emollient application (EM: -0·87 [95%CI 0·69-1·06] and CHG+EM: -0·73 [0·45-0·99]), compared to the SOC and CHG arms (Table 2); no CHG-related skin reactions occurred. INTERPRETATION: Bacterial colonization density was significantly reduced in babies receiving 1% CHG washes but colonization levels rebounded rapidly post-intervention. Emollient application improved skin condition but was associated with higher rates of S. aureus colonization. FUNDING: South African Medical Research Council; National Institutes of Health (TW010682).
format Online
Article
Text
id pubmed-8225683
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-82256832021-06-29 Impact of 1% chlorhexidine gluconate bathing and emollient application on bacterial pathogen colonization dynamics in hospitalized preterm neonates – A pilot clinical trial Dramowski, Angela Pillay, Sheylyn Bekker, Adrie Abrahams, Ilhaam Cotton, Mark F. Coffin, Susan E. Whitelaw, Andrew C. EClinicalMedicine Research Paper BACKGROUND: Chlorhexidine gluconate (CHG) body washes and emollient application may modulate bacterial pathogen colonization and prevent neonatal hospital-acquired infections. METHODS: This pilot, non-randomized, open-label trial, enrolled preterm neonates (1000-1500g; day 1-3 of life) at a tertiary hospital in Cape Town, South Africa. Participants were sequentially allocated to 4 trial arms (n=20 each): 1% aqueous CHG (CHG), 1% CHG plus emollient (CHG+EM), emollient only (EM) and standard of care (SOC: no antiseptic/emollient). Trial treatment/s were applied daily for 10 days (d) post-enrolment, documenting neonatal skin condition score. Anterior nose, neck, umbilical and perianal swabs for bacterial culture were collected at d1, d3, d10 and d16 post-enrolment, (±1 day), reporting pathogen acquisition rates and semi-quantitative bacterial colony counts. (ClinicalTrials.gov identifier: NCT03896893; trial status: closed). FINDINGS: Eighty preterm neonates (mean gestational age 30 weeks [SD 2]) were enrolled between 4 March and 26 August 2019. The bacterial pathogen acquisition rate (comparing d1 and d16 swabs) varied from 33·9% [95%CI 22·9-47·0] at the umbilicus, 39·3% [95%CI 27·6-52·4] at the neck, to 71·4% [95%CI 58·5-81·7] at both the nose and perianal region. At d10, CHG babies had reduced bacterial density detected from neck, umbilicus, and perianal swabs compared to other groups (see Table 3). Following intervention cessation, colonization density was similar across all trial arms, but S. aureus colonization was more prevalent among EM and CHG+EM babies. Neonatal skin condition score improved in babies receiving emollient application (EM: -0·87 [95%CI 0·69-1·06] and CHG+EM: -0·73 [0·45-0·99]), compared to the SOC and CHG arms (Table 2); no CHG-related skin reactions occurred. INTERPRETATION: Bacterial colonization density was significantly reduced in babies receiving 1% CHG washes but colonization levels rebounded rapidly post-intervention. Emollient application improved skin condition but was associated with higher rates of S. aureus colonization. FUNDING: South African Medical Research Council; National Institutes of Health (TW010682). Elsevier 2021-06-18 /pmc/articles/PMC8225683/ /pubmed/34195575 http://dx.doi.org/10.1016/j.eclinm.2021.100946 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Paper
Dramowski, Angela
Pillay, Sheylyn
Bekker, Adrie
Abrahams, Ilhaam
Cotton, Mark F.
Coffin, Susan E.
Whitelaw, Andrew C.
Impact of 1% chlorhexidine gluconate bathing and emollient application on bacterial pathogen colonization dynamics in hospitalized preterm neonates – A pilot clinical trial
title Impact of 1% chlorhexidine gluconate bathing and emollient application on bacterial pathogen colonization dynamics in hospitalized preterm neonates – A pilot clinical trial
title_full Impact of 1% chlorhexidine gluconate bathing and emollient application on bacterial pathogen colonization dynamics in hospitalized preterm neonates – A pilot clinical trial
title_fullStr Impact of 1% chlorhexidine gluconate bathing and emollient application on bacterial pathogen colonization dynamics in hospitalized preterm neonates – A pilot clinical trial
title_full_unstemmed Impact of 1% chlorhexidine gluconate bathing and emollient application on bacterial pathogen colonization dynamics in hospitalized preterm neonates – A pilot clinical trial
title_short Impact of 1% chlorhexidine gluconate bathing and emollient application on bacterial pathogen colonization dynamics in hospitalized preterm neonates – A pilot clinical trial
title_sort impact of 1% chlorhexidine gluconate bathing and emollient application on bacterial pathogen colonization dynamics in hospitalized preterm neonates – a pilot clinical trial
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225683/
https://www.ncbi.nlm.nih.gov/pubmed/34195575
http://dx.doi.org/10.1016/j.eclinm.2021.100946
work_keys_str_mv AT dramowskiangela impactof1chlorhexidinegluconatebathingandemollientapplicationonbacterialpathogencolonizationdynamicsinhospitalizedpretermneonatesapilotclinicaltrial
AT pillaysheylyn impactof1chlorhexidinegluconatebathingandemollientapplicationonbacterialpathogencolonizationdynamicsinhospitalizedpretermneonatesapilotclinicaltrial
AT bekkeradrie impactof1chlorhexidinegluconatebathingandemollientapplicationonbacterialpathogencolonizationdynamicsinhospitalizedpretermneonatesapilotclinicaltrial
AT abrahamsilhaam impactof1chlorhexidinegluconatebathingandemollientapplicationonbacterialpathogencolonizationdynamicsinhospitalizedpretermneonatesapilotclinicaltrial
AT cottonmarkf impactof1chlorhexidinegluconatebathingandemollientapplicationonbacterialpathogencolonizationdynamicsinhospitalizedpretermneonatesapilotclinicaltrial
AT coffinsusane impactof1chlorhexidinegluconatebathingandemollientapplicationonbacterialpathogencolonizationdynamicsinhospitalizedpretermneonatesapilotclinicaltrial
AT whitelawandrewc impactof1chlorhexidinegluconatebathingandemollientapplicationonbacterialpathogencolonizationdynamicsinhospitalizedpretermneonatesapilotclinicaltrial